<DOC>
	<DOCNO>NCT02916602</DOCNO>
	<brief_summary>A phase 3 study evaluate efficacy safety HCP1401</brief_summary>
	<brief_title>A Study Evaluate Efficacy Safety HCP1401 Stage 2 Hypertension Patients Not Controlled HCP0605</brief_title>
	<detailed_description>A randomized , double-blind , multicenter , phase 3 study evaluate efficacy safety HCP1401 stage 2 hypertension patient control HCP0605</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Chlorthalidone</mesh_term>
	<mesh_term>Losartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Hypertension patient satisfy condition Visit 1. patient take antihypertensive drug 140mmHg &lt; = sitSBP &lt; = 200mmHg patient n't take antihypertensive drug 160mmHg &lt; = sitSBP &lt; = 200mmHg 140mmHg &lt; = sitSBP &lt; = 200mmHg Visit 2 Patient receive 4 antihypertensive drug Patient 20mmHg difference sitSBP 10mmHg difference sitDBP 3 time BP measure Visit 1 Patient sitDBP &gt; = 120mmHg Visit 2 Patient secondary hypertension</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>